MIRA INFORM REPORT

 

 

Report Date :

17.01.2011

 

IDENTIFICATION DETAILS

 

Name :

ACG PAM PHARMA TECHNOLOGIES PRIVATE LIMITED

 

 

Registered Office :

127, Kandivali Industrial Estate, Kandivali West, Mumbai - 400067, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

21.02.1972

 

 

Com. Reg. No.:

015632

 

 

CIN No.:

[Company Identification No.]

U24239MH1972PTC015632

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMP15335F

 

 

PAN No.:

[Permanent Account No.]

AAACP4776H

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceuticals Machinery and their components.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (58)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 4481100

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and a reputed company having fine track. Financial position of the company appears to be sound. Fundamentals are strong and healthy. Trade relations are reported as fair. Business is active. Payments are reported to  be regular and as per commitments.

 

The company can be considered for normal for business dealings at usual trade terms and conditions.

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

LOCATIONS

 

Registered Office :

127, Kandivali Industrial Estate, Kandivali West, Mumbai - 400067, Maharashtra, India

Tel. No.:

91-22-30780700

Fax No.:

91-22-30780709

E-Mail :

vadana.nayak@acg-world.com

 

 

DIRECTORS

 

AS ON 05.08.2010

 

Name :

Mr. Singh Daljit Jasjit

Designation :

Director

Address :

2B Swapnalok L Jagmohandas Marg, Nepeansea Road, Mumbai – 400036, Maharashtra, India

Date of Birth/Age :

03.04.1943

Date of Appointment :

02.12.1972

 

 

Name :

Mr. Singh Daljit Ajit

Designation :

Whole Time Director

Address :

A -1, Brighton No.1, Rungta Lane, Nepeansea Road, Mumbai – 400036, Maharashtra, India

Date of Birth/Age :

20.01.1941

Date of Appointment :

01.11.1988

 

 

Name :

Mr. Singh Jasjit Karan

Designation :

Director

Address :

2B Swapnalok L Jagmohandas Marg, Nepeansea Road, Mumbai – 400036, Maharashtra, India

Date of Birth/Age :

23.07.1979

Date of Appointment :

25.11.2005

 

 

Name :

Mr. Chopra Jagmohanlal

Designation :

Director

Address :

4th Floor, 42 Tower B Jolly Maker A, Cuffe Parade, Mumbai – 400005, Maharashtra, India

Date of Birth/Age :

17.11.1933

Date of Appointment :

29.09.2006

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 05.08.2010

 

Names of Shareholders

No. of Shares

Singh Daljit Ajit

4401

Singh Daljit Jasjit

1102

Singh Jasjit Nandini

1100

Singh Jasjit Karan

1100

Singh Jasjit Priya

1100

Jeet Mercantile Private Limited, India

16002

TOTAL

24805

 

 

 

AS ON 05.08.2010

 

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Bodies corporate

 

64.51

Directors or relatives of directors

 

35.49

 

Total

100.00

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceuticals Machinery and their components.

 

 

Products :

ITEM CODE NO

PRODUCT DESCRIPTION

847990.04

Parts of Plant and Machinery for Chemicals and Pharmaceuticals

 

 

 

PRODUCTION STATUS AS ON (31.03.2010)

 

Particulars

Unit

 

Installed Capacity

Actual Production

Pharmaceuticals Machines

Nos.

 

2000

--

Accessories and Spares

Tons.

 

100

--

Machines

Nos.

 

--

1138

 

GENERAL INFORMATION

 

Bankers :

  • The Hong Kong and Shanghai Banking Corporation Limited, 52/60, Mahatma Gandhi Road, Fort, Mumbai – 400001, Maharashtra, India
  • State Bank of India, Kandivli Industrial Estate Branch, Near Hindustan Naka, Kandivli West, Mumbai – 400067, Maharashtra, India

 

 

Facilities :

SECURED LOAN

AS ON 31.03.2010 (Rs. In millions)

AS ON 31.03.2009 (Rs. In millions)

Cash Credit

0.000

9.233

TOTAL

0.000

9.233

 

UNSECURED LOAN

AS ON 31.03.2010 (Rs. In millions)

AS ON 31.03.2009 (Rs. In millions)

From Directors

10.323

10.323

TOTAL

10.323

10.323

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

B K Khare and Company

Chartered Accountant

Address :

706-708, Sharda Chambers, New Marine Lines, Mumbai – 400020, Maharashtra, India

 

 

Companies :

  • ACG Arts & Properties Private Limited
  • ACG Pharmapack Private Limited
  • ACG Pam-Pac Machines Private Limited (from 18.2.2010)
  • ACG Ajas Components Private Limited
  • ACG Associated Capsules Private Limited
  • ACG Inspection Systems Private Limited
  • Custom Capsules Private Limited
  • Packshield India Private Limited
  • Pam Glatt Pharma Technologies Private Limited
  • Sci-Tech Centre
  • ACG Real Estate Private Limited
  • PAM Intech Machines Private Limited
  • ACG Korsch Compression Technologies Private Limited
  • Nepean Holdings Private Limited

 

 

Wholly Owned Subsidiary :

Pam USA LLC, New Jersey, USA

 

 

Firms :

  • Amil Enterprises
  • Aries Components Mfg. and Company
  • Bulk Buyers
  • Capsulabs
  • Centercorp
  • Extra Han
  • Pharmagents

 

 

Foreign Companies :

  • PT. Universal Capsules Indonesia Inc
  • Universal Capsules L.L.C.
  • Universal Capsules Philippines Inc.
  • Amricaps
  • Symtech International Limited
  • First Venture Limited
  • Transworld Investments Limited
  • ACG Europe Limited
  • ACG Holdings (B.V.), Netherland
  • Lukaps DOO

 

 

 

 

 

 

 

 

 

 

 

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2010

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

25000

Equity Shares

Rs. 100each

Rs.2.500 millions

 

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

24805

Equity Shares

Rs. 100each

Rs.2.480 millions

 

 

 

 

 

NOTE

 

Of the above, 8000 Equity shares of Rs.100 each were allotted as fully paid up bonus shares by capitalisation of reserves and 800 Equity shares of Rs.100 each were allotted for consideration other than cash

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

2.480

2.480

2.480

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

1117.803

1031.268

913.358

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

1120.283

1033.748

915.838

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

9.233

144.784

2] Unsecured Loans

10.323

10.323

3.023

TOTAL BORROWING

10.323

19.556

147.807

DEFERRED TAX LIABILITIES

1.025

2.223

6.989

 

 

 

 

TOTAL

1131.631

1055.527

1070.634

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

187.918

191.925

212.113

Capital work-in-progress

32.138

22.592

5.934

 

 

 

 

INVESTMENT

273.472

272.602

211.158

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

185.664

261.925

361.127

 

Sundry Debtors

223.273

328.116

377.766

 

Cash & Bank Balances

42.853

20.426

5.301

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

514.088

257.463

582.107

Total Current Assets

965.878

867.930

1326.301

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

136.311

112.656

172.614

 

Other Current Liabilities

138.799

152.190

121.340

 

Provisions

52.665

34.676

390.918

Total Current Liabilities

327.775

299.522

684.872

Net Current Assets

638.103

568.408

641.429

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

1131.631

1055.527

1070.634

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income

1252.784

1108.325

931.756

 

 

Other Income

 

54.124

59.024

 

 

TOTAL                                     (A)

1252.784

1162.449

990.780

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Manufacturing Expenses

386.224

564.676

 

 

Employee’s Remuneration and Welfare Expenses

NA

204.949

158.212

 

 

Other Expenses

 

271.790

229.847

 

 

Increase / (Decrease) In Stock

 

87.097

(101.683)

 

 

TOTAL                                     (B)

NA

950.060

851.052

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

NA

212.389

139.728

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

NA

10.357

7.543

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

NA

202.032

132.185

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

NA

20.073

18.529

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

183.283

181.959

113.656

 

 

 

 

 

Less

TAX                                                                  (H)

101.426

64.049

40.072

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

81.857

117.910

73.584

 

 

 

 

 

Add

Earlier year’s adjustment

4.678

0.000

0.000

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

43.351

25.441

21.856

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

80.000

100.000

70.000

 

BALANCE CARRIED TO THE B/S

49.886

43.351

25.440

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

26.189

40.189

47.590

 

 

Capital Goods

0.000

0.000

10.109

 

 

Consumable Goods

0.000

0.000

0.207

 

TOTAL IMPORTS

26.189

40.189

57.906

 

 

 

 

 

 

Earnings Per Share (Rs.)

0.003

0.004

0.002

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

6.53

10.14

7.42

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

--

16.41

12.19

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

15.88

17.16

7.38

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.16

0.17

0.53

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.30

0.30

0.90

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.94

2.89

1.93

 

 

LOCAL AGENCY FURTHER INFORMATION

 

REVIEW OF PERFORMANCE

 

During the year the company made further strides on the export front. The Company's thrust on exports will continue with a view to ensure sustained growth

 

FORM 8

 

This form is for

Creation of charge

Corporate identity number of the company

U24239MH1972PTC015632

Name of the company

PAM PHARMACEUTICAL AND ALLIED MACHINERY COMPANY PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

127, Kandivali Industrial Estate, Kandivali West, Mumbai - 400067, Maharashtra, India

Type of charge

Book Debts

Others

Particular of charge holder

The Hong Kong and Shanghai Banking Corporation Limited, 52/60, Mahatma Gandhi Road, Fort, Mumbai – 400001, Maharashtra, India

Nature of description of the instrument creating or modifying the charge

Deed of Hypothecation  dated 25 March 2010 for Stocks & Book Debts, both present and future

Date of instrument Creating the charge

25.03.2010

Amount secured by the charge

Rs.100.000 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

Interest shall be payable by the Company. on the banking facilities as per banks tariff, subject however that the bank shall have the right to change the rate of interest after giving notice to the Company

 

Terms of Repayment

In consideration of banking facilities sanctioned/to be sanctioned by the Bank to the Company, the Company has hypothecated and charged to the bank by way of First Pari Passu Charge as a continuing security, the assets mentioned in the Agreement to secure the repayments of the advances together with interest cost and all other charges

 

Margin

The Company shall maintain such margin as may be specified by the bank from time to time

 

Extent and Operation of the charge

Charge over present and future current assets of the company as mentioned in the PART I and II of the Deed of Hypothecation  dated 25 March 2010,to the extent of Rs. 100 Million with interest cost and any other charges. In case the company fails to fulfill its obligation under the agreement, the bank shall be entitled to take possession of the hypothecated properties and sell them by public auction or private contract and utilize the proceeds in full or part settlement of its claims

Short particulars of the property charged

  • First Pari Passu Charge on all the Company's stock-in-trade both present and future including stocks of raw materials, work-in-progress, spares and stores and
  • finished goods (as per Schedule Part I attached) and All the company's present and future book debts, outstanding monies, receivables, claims due and owing

 

FIXED ASSETS

 

In Tangible Assets

 

  • Goodwill
  • SAP Software License

 

 

Tangible Assets

 

  • Leasehold Land
  • Buildings
  • Plant and Machinery
  • Computers
  • Furniture and Fixture
  • Office Equipments
  • Vehicles

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.30

UK Pound

1

Rs.71.73

Euro

1

Rs.60.40

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

6

--RESERVES

1~10

7

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

58

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.